Autonomix Medical, Inc. Common Stock (AMIX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Autonomix Medical, Inc. Common Stock (AMIX) has a cash flow conversion efficiency ratio of -0.491x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.89 Million) by net assets ($5.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AMIX equity to assets ratio to measure how much of total assets are equity-financed.
Autonomix Medical, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2022–2026)
This chart illustrates how Autonomix Medical, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Autonomix Medical, Inc. Common Stock (AMIX) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Autonomix Medical, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Autonomix Medical, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guyana Goldstrike Inc
V:GYA
|
N/A |
|
Kumho Industrial Co Ltd
KO:002995
|
0.632x |
|
CPU Softwarehouse AG
F:CPU2
|
-0.015x |
|
Jiangsu Huasheng Tianlong Photo
SHE:300029
|
0.320x |
|
Northbaze Group AB
ST:NBZ
|
-0.044x |
|
NOROO Paint & Coatings Co Ltd
KO:090355
|
-0.006x |
|
Diligent Media Corporation Limited
NSE:DNAMEDIA
|
0.005x |
|
Conduit Pharmaceuticals Inc.
NASDAQ:CDT
|
-0.015x |
Annual Cash Flow Conversion Efficiency for Autonomix Medical, Inc. Common Stock (2022–2026)
The table below shows the annual cash flow conversion efficiency of Autonomix Medical, Inc. Common Stock from 2022 to 2026. For the full company profile with market capitalisation and key ratios, see Autonomix Medical, Inc. Common Stock (AMIX) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $5.89 Million | $-12.28 Million | -2.083x | -104.33% |
| 2025-03-31 | $8.10 Million | $-8.26 Million | -1.020x | -16.99% |
| 2024-03-31 | $7.63 Million | $-6.65 Million | -0.872x | +69.73% |
| 2023-03-31 | $644.00K | $-1.85 Million | -2.880x | -1356.83% |
| 2022-03-31 | $1.96 Million | $-387.31K | -0.198x | -- |
About Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with … Read more